Close

Medtronic (MDT) Reports FDA Approval of New Recaptureable TAVR System

October 26, 2016 1:19 PM EDT Send to a Friend
Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login